Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality.
TLDR
In this paper, the authors summarized the biological characteristics of Fusobacterium nucleatum and the epidemiological associations between F. nucleatum, and highlighted the mechanisms by which F.ucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment.Abstract:
Colorectal cancer (CRC) is a common cancer worldwide with complex etiology. Fusobacterium nucleatum (F. nucleatum), an oral symbiotic bacterium, has been linked with CRC in the past decade. A series of gut microbiota studies show that CRC patients carry a high abundance of F. nucleatum in the tumor tissue and fecal, and etiological studies have clarified the role of F. nucleatum as a pro-carcinogenic bacterium in various stages of CRC. In this review, we summarize the biological characteristics of F. nucleatum and the epidemiological associations between F. nucleatum and CRC, and then highlight the mechanisms by which F. nucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment (TME). We also discuss the research gap in this field and give our perspective for future studies. These findings will pave the way for manipulating gut F. nucleatum to deal with CRC in the future.read more
Citations
More filters
Journal ArticleDOI
Oral microbiota in human systematic diseases
TL;DR: In this article , the authors discussed emerging and exciting evidence of complex and important connections between the oral microbes and multiple human systemic diseases, and the possible contribution of the oral microorganisms to systemic diseases.
Journal ArticleDOI
Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer
Cheng Kong,Lei Liang,Guang Liu,Lutao Du,Yongzhi Yang,Jianqiang Liu,Debing Shi,Xinxiang Li,Yan-yan Ma +8 more
TL;DR: The predictive model based on metagenomic, metabolomic and KO gene markers achieved a powerful classification performance for distinguishing EO-CRC from controls, suggesting that altered microbiome–metabolome interplay helps explain the pathogenesis of EO.CRC.
Journal ArticleDOI
Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
TL;DR: Gut microbiota and their metabolites influence the progression and causation of CRC, and the association analysis of metabolomics and gut microbiome will provide novel strategies for the prevention, diagnosis, and therapy of CRC.
Journal ArticleDOI
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim,Helena Kupcova Skalnikova,Jana Čížková,Veronika Cizkova,A Palanová,D. Horák,Jakub Mrázek +6 more
TL;DR: In this article , the authors examined associations between dysbiosis in the skin and gut microbiome and the melanoma growth using MeLiM porcine model of melanoma progression and spontaneous regression.
Journal ArticleDOI
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim,Helena Kupcova Skalnikova,Jana Čížková,Veronika Cizkova,A Palanová,D. Horák,Jakub Mrázek +6 more
TL;DR: In this article , the authors examined associations between dysbiosis in the skin and gut microbiome and the melanoma growth using MeLiM porcine model of melanoma progression and spontaneous regression.
References
More filters
Journal ArticleDOI
Prospective evaluation of dietary and lifestyle pattern indices with risk of colorectal cancer in a cohort of younger women.
Yiyang Yue,Jinhee Hur,Yin Cao,Fred K. Tabung,Fred K. Tabung,Molin Wang,Molin Wang,K. Wu,Mingyang Song,Xuehong Zhang,Yang Liu,Yang Liu,J.A. Meyerhardt,K. Ng,Stephanie A. Smith-Warner,Walter C. Willett,Walter C. Willett,Edward Giovannucci,Edward Giovannucci +18 more
TL;DR: In this paper, the authors found that hyperinsulinemic dietary and lifestyle patterns were associated with a higher risk of colorectal cancer (CRC) in younger women.
Journal ArticleDOI
Short chain fatty acids released by Fusobacterium nucleatum are neutrophil chemoattractants acting via free fatty acid receptor 2 (FFAR2).
Agnes Dahlstrand Rudin,Arsham Khamzeh,Vignesh Venkatakrishnan,Amina Basic,Karin Christenson,Johan Bylund +5 more
TL;DR: In this paper, the authors show that the major chemoattractants released during the growth of Fusobacterium nucleatum are short chain fatty acids (SCFAs), primarily acetate and butyrate.
Journal ArticleDOI
Prediction of Chronic Periodontitis Severity Using Machine Learning Models Based On Salivary Bacterial Copy Number.
Eunhye Kim,Seunghoon Kim,Hyun-Joo Kim,Hyoung-oh Jeong,Jaewoong Lee,Jinho Jang,Ji-Young Joo,Yerang Shin,Jihoon Kang,Ae Kyung Park,Ju-Youn Lee,Semin Lee +11 more
TL;DR: The results suggest that a well-designed combination of salivary bacteria can be used as a biomarker for classifying between a periodontally healthy group and a chronic periodontitis group.
Journal ArticleDOI
Proteomic analysis of Fusobacterium nucleatum growth in biofilm versus planktonic state.
TL;DR: Results confirmed that this metabolic pathway is important in the formation of the biofilm of F. nucleatum and in its pathogenicity, both in the oral cavity and in other locations of the body.
Journal ArticleDOI
Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer
Julia Butt,Julia Butt,Mazda Jenab,Michael Pawlita,Kim Overvad,Anne Tjønneland,Anja Olsen,Marie-Christine Boutron-Ruault,Marie-Christine Boutron-Ruault,Franck Carbonnel,Franck Carbonnel,Francesca Mancini,Francesca Mancini,Rudolf Kaaks,Tilman Kühn,Heiner Boeing,Antonia Trichopoulou,Anna Karakatsani,Domenico Palli,Valeria Pala,Rosario Tumino,Carlotta Sacerdote,Salvatore Panico,Bas Bueno-de-Mesquita,Carla H. van Gils,Roel Vermeulen,Elisabete Weiderpass,José Ramón Quirós,Eric J. Duell,María José Sánchez,Miren Dorronsoro,José María Huerta,Eva Ardanaz,Bethany Van Guelpen,Sophia Harlid,Aurora Perez-Cornago,Marc J. Gunter,Neil Murphy,Heinz Freisling,Dagfinn Aune,Tim Waterboer,David J. Hughes +41 more
TL;DR: Antibody responses to F. nucleatum proteins in prediagnostic serum samples from a subset of colorectal cancer cases and matched controls within the EPIC study were not associated with coloreCTal cancer risk.